Jennison Associates LLC Amicus Therapeutics, Inc. Transaction History

Jennison Associates LLC

$160 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$6.23 - $11.12 $21.8 Million - $39 Million	-3,502,726 Reduced 98.16%	65,788 $707,000
Q1 2022 May 11, 2022	SELL	$7.89 - $12.48 $14.3 Million - $22.7 Million	-1,816,756 Reduced 33.74%	3,568,514 $33.8 Million
Q4 2021 Feb 08, 2022	SELL	$9.82 - $12.44 $2.81 Million - $3.55 Million	-285,771 Reduced 5.04%	5,385,270 $62.2 Million
Q3 2021 Nov 09, 2021	SELL	$8.74 - $11.84 $792,228 - $1.07 Million	-90,644 Reduced 1.57%	5,671,041 $54.2 Million
Q2 2021 Aug 12, 2021	BUY	$8.71 - $10.72 $245,674 - $302,368	28,206 Added 0.49%	5,761,685 $55.5 Million
Q1 2021 May 11, 2021	BUY	$9.2 - $23.86 $9.48 Million - $24.6 Million	1,030,896 Added 21.92%	5,733,479 $56.6 Million
Q4 2020 Feb 05, 2021	SELL	$13.47 - $24.89 $8.85 Million - $16.4 Million	-657,222 Reduced 12.26%	4,702,583 $109 Million
Q3 2020 Nov 04, 2020	BUY	$12.89 - $15.89 $3.54 Million - $4.37 Million	274,966 Added 5.41%	5,359,805 $75.7 Million
Q2 2020 Aug 06, 2020	SELL	$8.86 - $15.69 $206,181 - $365,121	-23,271 Reduced 0.46%	5,084,839 $76.7 Million
Q1 2020 May 06, 2020	SELL	$6.63 - $11.16 $14 Million - $23.5 Million	-2,104,111 Reduced 29.17%	5,108,110 $47.2 Million
Q4 2019 Feb 07, 2020	BUY	$7.48 - $10.75 $67,985 - $97,706	9,089 Added 0.13%	7,212,221 $70.2 Million
Q3 2019 Nov 08, 2019	SELL	$8.02 - $13.25 $5.3 Million - $8.76 Million	-660,878 Reduced 8.4%	7,203,132 $57.8 Million
Q2 2019 Aug 06, 2019	SELL	$10.96 - $14.4 $8.34 Million - $11 Million	-760,927 Reduced 8.82%	7,864,010 $0
Q1 2019 May 10, 2019	SELL	$10.04 - $13.92 $12 Million - $16.7 Million	-1,199,435 Reduced 12.21%	8,624,937 $117 Million
Q4 2018 Feb 06, 2019	SELL	$8.38 - $13.44 $2.07 Million - $3.33 Million	-247,592 Reduced 2.46%	9,824,372 $94.1 Million
Q3 2018 Nov 08, 2018	SELL	$11.6 - $16.54 $264,514 - $377,161	-22,803 Reduced 0.23%	10,071,964 $122 Million
Q2 2018 Aug 02, 2018	SELL	$13.13 - $17.09 $3.16 Million - $4.11 Million	-240,700 Reduced 2.33%	10,094,767 $158 Million
Q1 2018 Apr 20, 2018	BUY	$13.76 - $17.12 $8.71 Million - $10.8 Million	633,354 Added 6.53%	10,335,467 $155 Million
Q4 2017 Jan 25, 2018	SELL	$12.51 - $16.24 $874,599 - $1.14 Million	-69,912 Reduced 0.72%	9,702,113 $140 Million
Q3 2017 Nov 03, 2017	BUY	$11.74 - $15.78 $115 Million - $154 Million	9,772,025	9,772,025 $147 Million

Others Institutions Holding FOLD

# of Institutions

311

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

Vanguard Group Inc Valley Forge, PA

28.8M
Shares

$260 Million
0.01% of portfolio
Perceptive Advisors LLC New York, NY

28.1M
Shares

$253 Million
7.83% of portfolio
Black Rock Inc. New York, NY

24.4M
Shares

$220 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

24M
Shares

$216 Million
0.05% of portfolio
Avoro Capital Advisors LLC New York, NY

23.2M
Shares

$209 Million
3.72% of portfolio

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Account